Back to Top

Journal Information  

  • Manuscript Submission Site: https://mc.manuscriptcentral.com/palliative  
  • Editorial Office Contact: PalMed_EO@liebertpub.com  
  • Support Contact: prosupport@liebertpub.com  
  • Journal Model: Hybrid (Open Access option)  
  • Blinding: Double Blind. Please include all identifying information is a separate title page 
  • File formatting requirement stage: Upon submission  
  • Instant Online Option (immediate publication of accepted version): No  
  • Submission Fee: $49 USD
  • Average time to initial decision: 20 days 

  Manuscript Types and Guidelines  

Original Articles  

  • 3,000-word limit  
  • Structured abstract of no more than 250 words, stating the background (Why was this report needed), objectives (What did you set out to do?), design (How did you go about doing it), setting/subjects (If this was a clinical trial, in what setting was it done and who were the subjects), measurements, results (What did you discover), and conclusions.  Please be sure to specifically identify the country of study in the Abstract, within the Settings/Subjects section. 
  • Key Message:  After the abstract, include a Key Message statement of 50 words or fewer to summarize the work and highlight its significance. Do not include any references in the Key Message. 
  • Maximum of eight (8) tables and/or figures 

Review Articles 

The reviews we publish are usually systematically constructed reviews, clearly following the relevant publication guidelines (such as PRISMA, RAMESES or ENTREQ) for the particular review style chosen. 

JPM publishes different types of review papers including systematic reviews, narrative reviews, scoping reviews, meta-analysis, meta-ethnography, and realist review. We also publish umbrella review papers (this is a review on a specific topic that compiles all the evidence from published review papers to give a critical overview of current knowledge).

  • 5,000-word limit
  • All manuscripts must be methodologically clear and rigorously conducted. 
  • Please indicate in your abstract and the introduction section the exact type of review that best describes your manuscript.  
  • Please indicate in your manuscript the specific guideline (such as PRISMA, RAMESES or ENTREQ) you followed in writing your paper.
  • If your review is registered (e.g. on PROSPERO) please indicate this in your cover letter and introduction section of the manuscript.
  • Unstructured abstract of no more than 300 words. 
  • Maximum of ten (10) tables and/or figures

Brief Report  

  • The results of preliminary studies, pilot programs, or small series on which an hypothesis can be formulated and tested in a subsequent study are good candidates for this category. 
  • 1,500-word limit 
  • Structured abstract of no more than 150 words 

Brief Communications  

  • 500-word limit  
  • May include one figure OR table  
  • Maximum of four (4) references  

Editorials/Special Report  

  • 1,000-word limit  

Case Discussions  

  • 2,000-word limit 
  • Structured abstract of no more than 150 words 
  • Format: Abstract; Introduction; Case Description; Discussion; References 

Letters to the Editor  

  • 500-word limit 
  • May include one figure OR table 
  • Reference citations are identical in style to those of full original articles, but should not exceed four(4). 

Palliative Care Specialists Series 

  

  • 3000 word limit (excluding abstract, tables/figures, references) 
  • Unstructured abstract (max 200 words) 
  • Topics must be pre-approved by the Series Editors to avoid multiple groups working on duplicate topics. Contact the editorial office with your idea/topic. 

Special Reports 

  • 2,000-word limit 
  • Unstructured abstract of no more than 150 words 

Fast Facts and Concepts 

  • 1,000-word limit 
  • No abstract 

Personal Reflections 

  

Book and Media Reviews 

  

  • 1,000-word limit 
  • No abstract

Word limits do NOT pertain to the abstract, disclosure statements, author contribution statements, funding information, acknowledgments, tables, figure legends, or references.  

 Description of Manuscript Types  

  • Brief Report- This category is for research that is less well developed than reported in an original manuscript. The results of preliminary studies, pilot programs, or small series on which a hypothesis can be formulated and tested in a subsequent study are good candidates for this category. JPM is  particularly interested in fostering the careers of junior investigators, or those new to the field of palliative medicine research. 
  • Brief Communications- Results of research or the development of ideas may be reported in a Brief Communication. Brief communications are often the richest source of new insights or serendipitous observations on which the future of the field may turn. This section is meant to transmit information that is much more ‘raw’ or ‘untested’ but holds promise in furthering the field through stimulating further research, discussion, or resolving controversy. 
  • Editorial/Special Report- From time to time, an unsolicited report from an important group or meeting, or a description of a phenomenon in the field, or a particular point of view deserves publication. These decisions rest solely with the Editor-in-Chief.  
  • Personal Reflection- One of the most widely read features in the journal, the personal reflections are written in a way that illustrates the personal engagement with the field—either its struggles or its joys or the complex combination of the two. Prose and poetry have all found a place here. Acceptance is at the sole discretion of the Managing Editor and Editor.  
  • Letters to the Editor-provide a forum for readers to comment on articles published in recent issues of Journal of Palliative Medicine.
  • Case Discussions in Palliative Medicine presents case-based examinations of topics relevant to the practice of palliative care. The Journal welcomes manuscripts that fit the traditional case report paradigm, e.g., a description of a rare diagnosis, unusual outcome, or new treatment modality. Reports of meaningful cases that do not necessarily report something “unusual,” but that would be of interest to a broad palliative care audience are also encouraged. We strongly encourage use of the existing evidence base. The main ‘outcome’ against which we will measure submissions is:  
    • will a community physician or nurse practitioner be able to look at this, and  
    • feel s/he has attended a worthwhile discussion, and  
    • come away with one thing s/he might do differently in his/her practice?  

In addition to traditional medical cases, The Journal welcomes cases illustrating issues that go beyond medical knowledge and patient care. Using the six ACGME competencies as an inspiration, we encourage submission of case discussions that address communication issues, ethics, professionalism, and systems-based practice.  

Clinical Palliative Care Program  

In order to improve the reader’s ability to evaluate and apply the results of research, include a paragraph describing the characteristics of the clinical program if it is involved in the research using the following structure. Program Structure. Indicate the parent organization or organizational home (e.g., hospital, free-standing hospice, home health agency, physician group, etc.). Indicate the payment sources (e.g., fee-for-service, value-based payment, philanthropy, etc.). Team Staffing. Indicate the total full-time equivalent (FTE) for each of the disciplines involved in the team (e.g., physician, advanced practice provider, registered nurse, social work, chaplain, pharmacist, etc.). Indicate the number with specialist palliative care certification. Do not include those who are matrixed but not designated to the palliative care team. Program Availability. Describe the settings in which palliative care is delivered (e.g., hospital, nursing home, ambulatory outpatient, home). Indicate hours and days per week that dedicated staff are available to patients and families. Indicate the source or mechanism of referrals, including the use of automatic referral triggers or criteria. Patient volume and interactions. Indicate the average daily census, the average visits per year, or penetration rate, average visits per patient and average length of service or stay in the palliative care program. You do not need to count the number of words in this required paragraph in the total word count of the manuscript.  

References 

Journal of Palliative Medicine uses Mary Ann Liebert's Vancouver reference format. Templates are available in Zotero and through the CSL Style Repository. An Endnote template is also available.  

Liebert Vancouver Style: Order of Citation  

  • Reference List:  Prepared in sequential order as cited in text.  

  • In-text Citations: All references must be cited in text in numerical order, set in superscript Arabic numerals outside of any punctuation.  Do not set reference numbers in parentheses or brackets.  To cite several references at once, use commas to separate non-sequential citations and use dashes to separate sequential citations; do not include spaces.  Ex:  3,7,12–15  

  • Journal titles should follow the abbreviation style of PubMed/Medline.  

  • Include among the references any articles that have been accepted but have not yet published; identify the name of publication and add "In Press." If the reference has been published online, provide the DOI number in place of the page range. 

Style Examples for Reference List:  

Type of Reference  

Punctuation and Order of Elements in Reference List  

Journal article with 1-3 authors  

Wang Q, Nambiar K, Wilson JM.  Isolating natural adeno-associated viruses from primate tissues with a high-fidelity polymerase. Hum Gene Ther 2021;32(23-24):1439-1449; doi: 10.1089/hum.2021.055 [insert article-specific DOI if available]. 

Journal article with more than 3 authors  

  

Pfister EL, DiNardo N, Mondo E, et al. Artificial miRNAs reduce human mutant Huntington throughout the striatum in a transgenic sheep model of Huntington's disease. Hum Gene Ther 2018;29(6):663–673; doi: 10.1089/hum.2017.199 [insert article-specific DOI if available]. 

Edited Book  

  

Herzog RW, Zolotukhin S, (eds).  A Guide to Human Gene Therapy. World Scientific Publishing Co. Pte. Ltd.: Singapore; 2010.  

Chapter in an Edited Book  

  

Nicklin SA, Baker AH.  Adenoviral Vectors. In: A Guide to Human Gene Therapy. (Herzog RW, Zolotukhin S. eds.) World Scientific Publishing Co. Pte. Ltd.: Singapore; 2010; pp. 21-36.  

Authored Book  

Isaacson W. The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of the Human Race. Simon & Schuster: New York, NY; 2021.  

Website  

  

Last name, first/middle initial(s) of author(s) [if available]. U.S. Food and Drug Administration. What is Gene Therapy? Silver Spring, MD; 2018. Available from: https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/what-gene-therapy  [Last accessed: month/date/year].  

Personal communications  

References that are unpublished (ie: personal communications, emails, letters) are not to be included in the reference list.  Instead, insert “Personal communication; [name], date” parenthetically at the point of citation within text.    

Using previously published images or tables as a reference  

  

Reused/adapted images, tables, or any published material must be officially cited as a reference in the reference list, and the author(s) of the submitted work must obtain written permission from the copyright holder.  Verbal approvals are not acceptable.  Any fees associated with the reuse or adaptation of any material is the sole responsibility of the author(s). 

 

PaperPal Preflight

The Paperpal Preflight service is available for this journal. PaperPal Preflight allows authors to check their Original Research manuscripts for common errors prior to submitting a manuscript for consideration. Please note that this does not guarantee that your paper will pass all submission or other checks, nor that it will be considered for review.

The checks are configured for Original Research manuscripts only and may not be applicable to other manuscript types. There may be additional requirements for submission. Please review the full instructions for authors for guidelines.

The basic service is free. PaperPal preflight offers an optional fee-based service that will provide a report showing tracked changes and potential modifications. Please note that if this service is used, a clean copy of the manuscript must be uploaded to the submission system.

There is no obligation to use either the free or paid service. No editorial, review, nor any other decisions will be dependent on its use.

All manuscripts must be submitted through the journal’s ScholarOne Manuscripts site.

Millions of papers are published every year. Make yours stand out.

The things that matter to you are the things that matter to us: speed, quality, access, and exposure. We work hand-in-hand with you to rapidly prepare, submit, publish, and disseminate your research to ensure it receives the attention and long-term impact it deserves.
 

Our unique publishing experience delivers:
  • One-on-one expert guidance and communication, from pre-submission inquiries through to post-publication marketing
  • Prompt first editorial decision, with referral options available to other leading journals in our portfolio
  • Rigorous peer review and editorial oversight from leading specialists in your field
  • No limitations on page count or number of color figures to safeguard the scientific integrity of your work
  • Zero-embargo green Open Access policy ensures that you comply with funder mandates; you have the option to post the accepted version of your manuscript to your institutional repository or personal website immediately upon publication of the Version of Record
  • Rapid online-first publication ensures your work is available to read, cite, and make an impact as soon as possible
  • All article pages are search engine optimized (SEO) using the latest technologies, making it easy for readers to find and access your work through online searches
  • Immediate deposit of your work to PubMed and other indexing services upon publication, maximizing your discoverability across all major research platforms
  • Free 30-day access to your published research to share your work among colleagues, social networks, and with anyone who may be interested in your work
  • Availability in library and institutional resource collections in more than 170 countries as well as through Research4Life, which makes your research freely available in developing countries
  • Opportunity for your work to be featured in our highly successful marketing and public relations campaigns that amplify your impact

 

Mary Ann Liebert, Inc. has partnered with Editage and Impact Science to provide you with an additional dynamic suite of specialized editorial services to ensure your manuscript has the impact it deserves. Learn more about how we can take your paper to the next level with our pre-submission English Language Editing and English-Language Translation with Editing Services, as well as our post-publication Research Promotion Services – including infographics, video abstracts, plain language summaries, and more.

Visit our Author Services portal now for more information and to get started!

 

All Editage services are fee-based services that authors can opt-into as an added author benefit to amplify the readability, visibility, findability, and shareability of their work.

Publishing Open Access

Open Access enables you to publish your work under a Creative Commons (CC-BY) copyright license in our esteemed hybrid journals. Publishing Open Access makes your article immediately available to read globally, increasing the visibility and potential impact of your research.

Benefits of Publishing Open Access:
  • Maximum visibility: open access articles are freely available online upon publication with no subscription needed
  • Authors retain copyright, allowing broad dissemination of research
  • Articles can be freely shared in repositories and research networks without restrictions
  • Automatic submission to PubMed Central and PMC mirror sites, when applicable*
  • Open access articles are listed with an OA icon in journal tables of content (TOC), TOC email alerts, and in marketing announcements
Choosing Open Access

Once your article has been accepted for publication, you will receive an email with information on how to order open access. An Article Processing Charge (APC) is required to cover the cost of Open Access publication and article processing. Once payment is received your article will be published Open Access.

Copyright and Licensing

Under Open Access, authors retain copyright via a Creative Commons license. Authors may choose between the Creative Commons (CC BY) license and CC BY-Noncommercial (CC BY-NC) license.

  • The CC BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
  • The CC BY-NC license permits any noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.

*Please note that PubMed Central, not the Publisher, has sole control over when the paper is made live on PMC.

You can find out more about additional publication services, browse our portfolio of fully open access journals, read FAQs, and more on our Liebert Open Access page or by contacting openaccess@liebertpub.com.

Publishing Services Fees support the rigorous end-to-end management, oversight, and publication of your manuscript. This includes the maintenance of the Journal’s submission system; editorial processes including peer review, production management, typesetting, and copyediting; deposit to indexing and discovery services; online article hosting and archiving; and marketing to ensure the greatest level of visibility and impact for your work for the long-term.

All new manuscripts submitted to Journal of Palliative Medicine will be assessed the following mandatory Publishing Services Fees:

Submission Fee: $49

Investment in the long-term impact of your manuscript

Journal of Palliative Medicine offers a number of optional ways to increase the impact of your published work:

Color Figures: Publishing figures in color ensures the detailed nuances of art, images, charts, and figures are accurately and vividly conveyed to readers. Online publication of color figures is free of charge. To publish color figures in print, a fee of $800 applies and covers an unlimited number of figures.

Open Access: Open Access guarantees the broadest possible discoverability, visibility, and access for your work in perpetuity. When you choose to publish open access with us, you become part of an innovative and vibrant community committed to research quality, transparency, and inclusivity. An Article Processing Charge (APC) of $4,000 applies to publishing open access in this journal. For more information on our open access program, click here.

Post-Publication/Retrospective Open Access: Post-publication/retrospective open access applies a CC BY license to your previously published manuscript. Because this option requires the re-processing and re-deposit of your manuscript to hosting platforms and indexing services, a fee of $1,000 applies in addition to the above-mentioned APC.

Errata: Prior to publication, you will receive two (2) proofs of your article to review for accuracy and to ensure the manuscript meets your expectations. Should you require a correction after approval of the final proof and subsequent publication of your manuscript, you may be assessed a fee of $100/affected page, depending on the nature of the request.

Research Promotion Services: Mary Ann Liebert, Inc. has partnered with Editage and Impact Science to provide a dynamic suite of specialized services to ensure your manuscript has the impact it deserves. Click here to learn more about our post-publication Research Promotion Services including infographics, video abstracts, plain language summaries, and more.
 

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.